Business Wire

CA-ANDERSEN-GLOBAL

9.7.2020 12:36:12 CEST | Business Wire | Pressemeddelelse

Del
Andersen befæster sin tilstedeværelse i Europa

Efter at have opereret under navnene Andersen Tax, Andersen Legal og Andersen Tax & Legal vil medlemmerne af Andersen Global i Europa nu operere under et enkelt brand: ”Andersen”, hvilket viser det globale skatte- og advokatfirmas harmoniserede og homogene tilgang. Der vil ske lignende brandændringer i andre regioner rundt om i verden året igennem.

Denne bekendtgørelse kommer i hælene på de amerikanske medlemsfirmaers overgang til brandet ”Andersen” fra ”Andersen Tax” sidste år. I alt vil medlemsfirmaer i 12 europæiske lande – Cypern, Tyskland, Grækenland, Ungarn, Irland, Italien, Luxembourg, Polen, Portugal, Spanien, Schweitz og Storbritannien – tage Andersen-brandet til sig. Overgangen af OrienTax og Szabo Keleman & Partners markerer introduktionen af Andersen-brandet i Ungarn. Derudover vil B.A Tax Accountants tage brandet til sig, når de bliver en del af teamet i Luxembourg.

Inden for Europa er Andersen Global også til stede i Østrig, Bosnien og Herzegovina, Bulgarien, Kroatien, Kazakhstan, Moldova, Nederlandene, Nordmakedonien, Republikken Kosovo, Rumænien, Serbien, Slovakiet, Slovenien og Ukraine gennem sine samarbejdende firmaer og har planer om i fremtiden at udvide sit regionale fodaftryk i Central- og Østeuropa samt Skandinavien.

Optagelsen af Andersen-brandet i Europa er den bedste repræsentant for den komplette pakke af tjenester, som organisationen tilbyder sine kunder internationalt, inkl. juridiske tjenester i 86 lande, hvoraf 23 er i Europa.

”Vores fælles brand, Andersen, afspejler vores »én samlet virksomhed«-kultur og omfatter alt, hvad vi foretager os som en global organisation. Det kendetegner vores evne til at levere den bedste service indenfor branchen og vores dybe engagement i investering i vores folk,” siger Mark Vorsatz, formand for Andersen Global og administrerende direktør i Andersen. ”Hvert eneste medlem og samarbejdende firma, der er del af vores organisation, fremmer forvaltning og bibeholder gennemsigtighed. Vores globale organisation fortsætter med at været drevet af kunders behov og erkendelsen af, at vi bedst servicerer vores kunder med uafhængige og sammenhængende tjenester.”

Overgangen til Andersen-brandet i Europa er en milepæl for den globale organisation, som tog sin begyndelse i 2002, da 23 forhenværende Arthur Andersen skattepartnere skabte skattefirmaet WTAS. I 2014 tog gruppen brandet Andersen Tax til sig, da det bedst repræsenterede firmaets værdier, kunden først- kultur, forvaltning og gennemsigtighed. Organisationen er vokset eksponentielt siden etableringen af Andersen Global (tidligere WTAS Global) af det amerikanske grundlæggermedlem Andersen Tax LLC i 2013. Den europæiske region begyndte med kun to steder i 2013 og er siden vokset til mere end 50 steder, med flere end 2.000 skatte- og juridiske rådgivere og flere end 300 partnere i dag.

”Mange lande og regioner, såsom Storbritannien, presser på for at revisionsfirmaer adskiller deres revisions- og skattepraksis for at sikre integritet og uafhængighed,” siger Paolo Mondia, Co-Regional Managing Director in Europa. ”Vi har et konkurrencemæssigt forspring på det europæiske marked, hvor kombinerede skatte- og juridiske tjenester på uafhængig vis hører til undtagelsen, og vores kunder har været ekstremt modtagelige overfor denne model.”

Andrea De Vecchi, Co-Regional Managing Director in Europe, tilføjer: ”Ved at yde både juridiske og skattemæssige tjenester har vi været i stand til at udvide vores regionale og globale fodaftryk, forbedre vores serviceudbud og få fordelene og ressourcerne fra et globalt firma til vores kunder på en gnidningsfri måde.”

Gennem hele 2020 medlemsfirmaer over hele verden vil optage Andersen-brandet, mens den globale organisation vil fortsætte med at give mere dybde på afgørende markeder, herunder Afrika og Mellemøsten. Det er visionen at udvikle en gnidningsfri, professionel tjenestemodel med den bedste service i branchen rundt om i verden.

Andersen Global er en international sammenslutning af juridisk separate, uafhængige medlemsfirmaer, bestående af skatte- og juraeksperter fra hele verden. Siden oprettelsen i 2013 af det amerikanske medlemsfirma Andersen Tax LLC har Andersen Global nu over 5.000 eksperter globalt og er repræsenteret på over 177 lokaliteter via sine medlems- og samarbejdsfirmaer.

Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye